AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 173 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,059,881 | -32.2% | 1,423,408 | -15.6% | 0.00% | -50.0% |
| Q2 2023 | $16,318,409 | -20.6% | 1,685,786 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $20,543,742 | +219.4% | 1,874,429 | +25.9% | 0.00% | +100.0% |
| Q4 2022 | $6,431,249 | -41.7% | 1,488,715 | +1.5% | 0.00% | -50.0% |
| Q3 2022 | $11,031,000 | -62.0% | 1,467,029 | -49.3% | 0.00% | -50.0% |
| Q2 2022 | $29,054,000 | -22.9% | 2,890,904 | -5.0% | 0.00% | -20.0% |
| Q1 2022 | $37,668,000 | -65.3% | 3,042,680 | -36.0% | 0.01% | -61.5% |
| Q4 2021 | $108,648,000 | -26.7% | 4,750,719 | -29.1% | 0.01% | -35.0% |
| Q3 2021 | $148,323,000 | +216.0% | 6,702,366 | +85.1% | 0.02% | +233.3% |
| Q2 2021 | $46,936,000 | +1078.1% | 3,621,692 | +1080.9% | 0.01% | +500.0% |
| Q1 2021 | $3,984,000 | -64.5% | 306,686 | -62.2% | 0.00% | -50.0% |
| Q4 2020 | $11,234,000 | +510.9% | 812,324 | +550.8% | 0.00% | – |
| Q3 2020 | $1,839,000 | +19.7% | 124,824 | +32.1% | 0.00% | – |
| Q2 2020 | $1,536,000 | +89.9% | 94,495 | +69.4% | 0.00% | – |
| Q1 2020 | $809,000 | -83.7% | 55,783 | -77.3% | 0.00% | -100.0% |
| Q4 2019 | $4,970,000 | +3693.9% | 245,280 | +904.2% | 0.00% | – |
| Q3 2019 | $131,000 | -12.1% | 24,426 | +7.8% | 0.00% | – |
| Q2 2019 | $149,000 | -30.4% | 22,649 | -30.9% | 0.00% | – |
| Q1 2019 | $214,000 | -64.0% | 32,794 | -62.4% | 0.00% | – |
| Q4 2018 | $595,000 | +78.1% | 87,328 | +73.6% | 0.00% | – |
| Q3 2018 | $334,000 | -22.1% | 50,302 | -33.9% | 0.00% | – |
| Q2 2018 | $429,000 | -86.4% | 76,139 | -87.5% | 0.00% | -100.0% |
| Q1 2018 | $3,151,000 | +88.9% | 607,361 | +65.0% | 0.00% | – |
| Q4 2017 | $1,668,000 | -53.5% | 368,189 | -35.6% | 0.00% | -100.0% |
| Q3 2017 | $3,585,000 | +3.8% | 571,552 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $3,453,000 | -47.3% | 563,293 | -36.9% | 0.00% | 0.0% |
| Q1 2017 | $6,546,000 | +40812.5% | 892,270 | +11061.7% | 0.00% | – |
| Q4 2016 | $16,000 | +166.7% | 7,994 | +280.8% | 0.00% | – |
| Q3 2016 | $6,000 | 0.0% | 2,099 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | 0.0% | 2,099 | -2.6% | 0.00% | – |
| Q1 2016 | $6,000 | +200.0% | 2,155 | +104.3% | 0.00% | – |
| Q4 2015 | $2,000 | -33.3% | 1,055 | +5.5% | 0.00% | – |
| Q3 2015 | $3,000 | 0.0% | 1,000 | -5.2% | 0.00% | – |
| Q2 2015 | $3,000 | – | 1,055 | +1890.6% | 0.00% | – |
| Q1 2015 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 53 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 53 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |